Raw264.7 cell directional polarization M1 macrophage combined reagent as well as preparation method and application thereof

Through the use of specific combination reagents, including components such as LPS, M-CSF, GM-CSF, IFNr, BSA, trehalose and glycerol, 90 of Raw264.7 cells are efficiently directed polarized M1 macrophages within 24 hours. 90 %purity solves the problems of low induction rate and low purity in the prior art, and ensures the freezing and thermal stability of the reagent.

CN118956749APending Publication Date: 2024-11-15ELARITE (WUHAN) BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410968783.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing Raw264.7 cells have low success rate in induced M1 macrophages, and the proportion of induced M1 macrophages is low, making it difficult to achieve efficient and high-purity directed polarization.

Method used

Provide a combination reagent including induction reagent, special culture medium and digestive medium. Through specific preparation steps and component ratios, 90% of the M1 macrophage purity can be achieved within 24 hours. The induction reagents include LPS and M-CSF. , GM-CSF, IFNr, BSA, trehalose and glycerol and other components, and the inducer freeze and thermal stability are good.

Benefits of technology

It has achieved efficient induction of 90% purity of M1 macrophages in a short period of time (24 hours), solving the problems of low induction rate and low purity, and the inducer is still effective under frozen storage and heat treatment conditions, and is simple to operate and suitable for promotion and use. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118956749A_ABST
    Figure CN118956749A_ABST
Patent Text Reader

Abstract

The invention provides a Raw264.7 cell directionally polarized M1 macrophage combined reagent as well as a preparation method and application thereof. The combined reagent comprises an induction reagent, wherein the inducing reagent comprises the following components: at least one of 8 to 10 g / L of NaCl, 0.5 to 1.1 g / L of KCl, 0.2 to 0.5 g / L of KH2PO4, 0.5 to 1.4 g / L of Na2HPO4, 0.05 to 0.1 g / L of NaHCO3, 0.1 to 1 g / L of LPS, 0.1 to 1 g / L of M-CSF, 0.1 to 1 g / L of GM-CSF, 0.1 to 0.5 g / L of IFNr, 0.1 to 3 g / L of BSA, 10 to 50 g / L of trehalose and 0.1 to 1% of glycerin. The reagent provided by the invention has the advantages of short time for directionally polarizing the Raw264.7 cell to the M1 type macrophage, high induction rate, good cryopreservation stability and thermal stability, simple and convenient overall operation, and suitableness for vigorous popularization and application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biomedicine, and in particular relates to a Raw264.7 cell-directed polarization M1 macrophage combination reagent, and a preparation method and application thereof. Background Art

[0002] Macrophages are a heterogeneous group of bone marrow cells in the innate immune system that participate in several processes under physiological and pathological conditions. They are particularly active in inflammation and infection. In this case, blood monocytes are recruited into tissues, where they differentiate into macrophages. Among them, M1 macrophages are called classical macrophages, which are polarized by IFN-γ and LPS, release pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-12, and IL-23, and have enhanced antigen presentation and phagocytic abilities. They have strong microbial killing properties and can promote the occurrence of adaptive immune responses.

[0003] M1 macrophages play an important role in many diseases such as chronic recurrent inflammation of the gastrointestinal tract, autoimmune diseases, demyelinating diseases of the CNS, rheumatoid arthritis, obesity, and intracellular pathogen infection. Research on the immune role and mechanism of M1 in various diseases can provide technical and theoretical support for the treatment of various diseases. The most common M1 macrophage research model is the directional induction of Raw264.7 cells into M1 macrophages through LPS and IFN-γ. However, Raw264.7 cells are extremely sensitive, and the existing Raw264.7 cell line induction method has a low success rate, and the proportion of induced M1 macrophages is low.

[0004] Therefore, it is urgent to improve the existing technology and provide a short-time and high-induction rate method to solve the above problems. Summary of the invention

[0005] In view of this, the present invention provides a ready-to-use Raw264.7 cell polarized M1 macrophage combination reagent and a preparation method and application thereof. The combination reagent of the present invention can polarize Raw264.7 cells into M1 macrophages to a purity of 90% within 24 hours.

[0006] In order to achieve the above object, the present invention adopts the following technical solutions:

[0007] A combination reagent for polarizing Raw264.7 cells to M1 macrophages, the combination reagent comprising an induction reagent; the induction reagent comprising the following components: NaCl 8-10 g / L, KCl 0.5-1.1 g / L, KH2PO4 0.2-0.5 g / L, Na2HPO4 0.5-1.4 g / L, NaHCO3 0.05-0.1 g / L, LPS 0.1-1 g / L, M-CSF 0.1-1 g / L, GM-CSF 0.1-1 g / L, IFNr 0.1-0.5 g / L, and at least one of BSA 0.1-3 g / L, trehalose 10-50 g / L, and glycerol 0.1-1%.

[0008] In some specific embodiments, preferably, the induction reagent includes the following components: NaCl 8.4 g / L, KCl 1.0 g / L, KH2PO4 0.3 g / L, Na2HPO4 0.86 g / L, NaHCO3 0.08 g / L, LPS 0.3 g / L, M-CSF 0.4 g / L, GM-CSF 0.65 g / L, IFNr 0.35 g / L, and at least one of BSA 2 g / L, trehalose 25 g / L, and glycerol 0.8%.

[0009] Furthermore, the combination reagent also includes a special culture medium, which includes the following components: 5-20% fetal bovine serum, 0.1-1 g / L 2-mercaptoethanol, 0.5-2 g / L L-alaninamide, 0.5-2 g / L L-glutamine, and RPMI1640 basal culture medium.

[0010] Furthermore, the combination reagent also includes a digestion medium, which includes the following components: NaCl 8-10 g / L, KCl 0.5-1.1 g / L, KH2PO4 0.2-0.5 g / L, Na2HPO4 0.5-1.4 g / L, 2,6-dimethylaniline 10-20 g / L, and EDTA-2Na 0.1-1 g / L.

[0011] The preparation method of the above-mentioned combination reagent, the preparation steps of the induction reagent in the combination reagent are as follows: first take NaCl, KCl, KH2PO4, Na2HPO4, and NaHCO3 and dissolve them in sterilized ultrapure water, stir to dissolve, then add at least one of BSA, trehalose, and glycerol, stir to dissolve, and then adjust the pH to 7.2-7.4, make up to volume, filter through a 0.22μm filter membrane to sterilize, and store at 4°C to obtain a buffer solution; add LPS, M-CSF, GM-CSF, and IFNr to the above-mentioned buffer solution, gently blow and mix, and store at -20°C away from light to obtain the induction reagent.

[0012] Furthermore, the preparation steps of the special culture medium in the combination reagent are as follows: take 2-mercaptoethanol, L-alanineamide, and L-glutamine, add RPMI1640 basal culture medium, stir to dissolve in the dark, then add fetal bovine serum, mix well, and then adjust the pH to 7.2-7.4, filter through a 0.22μm filter membrane for sterilization, and store at 4°C in the dark to obtain a special culture medium.

[0013] Furthermore, the preparation steps of the digestion medium in the combination reagent are as follows: take NaCl, KCl, KH2PO4, Na2HPO4, and 2,6-dimethylaniline and dissolve them in sterilized ultrapure water, stir to dissolve, then add EDTA-2Na, stir to dissolve, then adjust the pH to 7.2-7.4, make up to volume, filter through a 0.22μm filter membrane to sterilize, and store at 4°C to obtain the digestion medium.

[0014] The method for obtaining M1 macrophages by polarizing Raw264.7 using the above-mentioned combination reagent comprises the following steps:

[0015] S1, pipette Raw264.7 cells, centrifuge, discard the supernatant, resuspend the cell pellet with a special culture medium, count the cells, adjust the cell density, and inoculate in a cell culture dish;

[0016] S2, add induction reagent, transfer to CO2 incubator at 37℃ and culture for 22-26h, remove supernatant, add special culture medium, shake to wash, and discard supernatant;

[0017] S3, add digestion medium, shake to soak, and incubate in a CO2 incubator at 37°C for 2 to 5 minutes, and digestion is complete;

[0018] S4. Collect the digested cells by blowing the cell dish, centrifuge, discard the supernatant, and resuspend the cell pellet with PBS buffer to obtain M1 macrophages.

[0019] Furthermore, in step S1, the cell density is 1 to 5×10 5 / mL, and the centrifugation conditions were all 140-160g for 2-4min; the amount of induction reagent added in step S2 was 1 μL of induction reagent added to 1mL of cell suspension; the centrifugation conditions in S3 were all 140-160g for 2-4min.

[0020] A ready-to-use Raw264.7 cell polarization M1 macrophage kit, the kit comprising the above-mentioned combined reagent.

[0021] Compared with the prior art, the present invention has the following beneficial effects:

[0022] The ready-to-use Raw264.7 cell-directed polarization M1 macrophage combination reagent provided by the present invention can achieve an induction rate of 99% in a short time (only 24 hours), solving the problems of high difficulty and low purity of Raw264.7 cell polarization M1; the inducer has good freezing stability (10 times of repeated freezing and thawing at -20°C still does not affect the induction effect) and good thermal stability (after 14 days of thermal acceleration treatment at 37°C, the induction effect is still not affected); in addition, the overall reagent preparation, induction process, etc. are simple to operate, and are suitable for popularization and use. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 These are microscope images of the reagents and blank control group after induction in Examples 1-3 of the present invention.

[0024] Figure 2 This is a flow cytometry test result diagram of the reagent and blank control group after induction in Example 1 of the present invention.

[0025] Figure 3 These are microscope images of the reagents and the blank control group after induction in Example 1 and Comparative Example 1 of the present invention.

[0026] Figure 4 This is a flow cytometry test result diagram of the reagents and the blank control group after induction in Example 1 and Comparative Example 1 of the present invention.

[0027] Figure 5 These are microscope images of the reagents and the blank control group after induction in Example 1 and Comparative Example 2 of the present invention.

[0028] Figure 6 The flow cytometer detection results after induction of the reagents and the blank control group in Example 1 and Comparative Example 2 of the present invention are shown.

[0029] Figure 7 These are microscope images of the reagents after repeated freeze-thawing in Example 4 and Comparative Example 3 and the blank control group after induction.

[0030] Figure 8 These are microscope images of the reagents after repeated freeze-thawing in Example 4 and Comparative Example 3 and the blank control group after induction.

[0031] Fig. 9 These are microscope images of the reagents after heating treatment in Example 4 and Comparative Example 3 and the blank control group after induction. DETAILED DESCRIPTION

[0032] The present invention is further described in detail below in conjunction with specific embodiments so that those skilled in the art can understand the present invention more clearly.

[0033] Sources and physical and chemical parameters of key test materials:

[0034] Lipopolysaccharide (LPS) was purchased from Med Chem Express LLC (MCE).

[0035] Macrophage colony stimulating factor (M-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and interferon (IFNr) were purchased from ACRO Biosystems.

[0036] RPMI1640 basal culture medium was purchased from Procell Life Science Co., Ltd.

[0037] Example 1

[0038] This embodiment provides a ready-to-use Raw264.7 cell-directed polarization M1 macrophage combination reagent and its preparation method and application. The combination reagent includes an induction reagent, a special culture medium, and a digestion culture medium. The specific components of each reagent are shown in Table 1 below.

[0039] Table 1 Details of the specific components of induction reagents, special culture medium, and digestion medium

[0040]

[0041]

[0042] Prepare each reagent according to the component details in Table 1, where the induction reagent preparation steps are as follows: first dissolve NaCl, KCl, KH2PO4, Na2HPO4, and NaHCO3 in sterilized ultrapure water and stir to dissolve, then add BSA, trehalose, and glycerol and stir to dissolve, then adjust the pH to 7.2, make up the volume, filter through a 0.22 μm filter membrane to sterilize, and store at 4°C to obtain a buffer solution; add LPS, M-CSF, GM-CSF, and IFNr to the above buffer solution, gently blow to mix, and store at -20°C away from light to obtain the induction reagent.

[0043] The steps for preparing the special culture medium are as follows: take 2-mercaptoethanol, L-alanineamide, and L-glutamine, add them to RPMI1640 basal culture medium, stir to dissolve in the dark, then add fetal bovine serum, mix well, then adjust the pH to 7.2, filter through a 0.22 μm filter membrane to sterilize, and store at 4°C in the dark to obtain the special culture medium.

[0044] The steps for preparing the digestion medium are as follows: dissolve NaCl, KCl, KH2PO4, Na2HPO4, and 2,6-dimethylaniline in sterilized ultrapure water, stir to dissolve, then add EDTA-2Na, stir to dissolve, adjust the pH to 7.2-7.4, make up to volume, filter through a 0.22 μm filter membrane to sterilize, and store at 4°C to obtain the digestion medium.

[0045] Furthermore, a method for polarizing Raw264.7 to obtain M1 macrophages using the above-prepared combination reagent comprises the following steps:

[0046] S1. Pipette Raw264.7 cells, centrifuge at 150 g for 3 min, discard the supernatant, resuspend the cell pellet in a special culture medium, count the cells, and adjust the cell density to 2.5 × 10 5 / mL, inoculated in cell culture dishes;

[0047] S2, add 1 μL of induction reagent to every 1 mL of cell suspension, transfer to a CO2 incubator at 37°C and culture for 24 h, observe the cell state under a microscope and take photos, remove the supernatant, add special culture medium, shake to wash, and discard the supernatant;

[0048] S3, add digestion medium, shake to soak, and incubate in a CO2 incubator at 37°C for 2 minutes, and the digestion is complete;

[0049] S4. Collect the digested cells by blowing the cell dish, centrifuge at 150g for 3 min, discard the supernatant, and resuspend the cell pellet with PBS buffer to obtain M1 macrophages.

[0050] Example 2

[0051] This embodiment provides a ready-to-use Raw264.7 cell-directed polarization M1 macrophage combination reagent and its preparation method and application. The raw materials and methods are basically the same as those in Example 1, except that the concentrations of the components in each reagent are different. The specific component concentrations are detailed in Table 2.

[0052] Table 2 Details of the specific components of induction reagents, special culture medium, and digestion medium

[0053]

[0054]

[0055] Example 3

[0056] This embodiment provides a ready-to-use Raw264.7 cell-directed polarization M1 macrophage combination reagent and its preparation method and application. The raw materials and methods are basically the same as those in Example 1, except that the concentrations of the components in each reagent are different. The specific component concentrations are detailed in Table 3.

[0057] Table 3 Details of the components of induction reagents, special culture medium, and digestion medium

[0058]

[0059]

[0060] Example 4

[0061] The present embodiment provides a ready-to-use Raw264.7 cell-directed polarization M1 macrophage combination reagent and a preparation method and application thereof. The raw materials and methods are basically the same as those in Example 1, except that: the material components in the induction reagent are different; in addition, the induction method is basically the same as that in Example 1, but there are two situations, one of which is to repeatedly freeze and thaw the induction reagent 10 times before induction, and the other is to heat accelerate the induction reagent at 37°C for 14 days before induction, and the rest remain unchanged. The specific differences in the induction reagents are shown in Table 4.

[0062] Table 4 Specific induction reagents details

[0063]

[0064] Comparative Example 1

[0065] This comparative example provides a ready-to-use Raw264.7 cell-directed polarization M1 macrophage combination reagent and its preparation method and application. Its raw materials and methods are basically the same as those in Example 1, except that: the types of induction reagents are different and the corresponding induction times are different, and the rest remain unchanged. The specific induction reagents and corresponding induction times are shown in Table 5.

[0066] Table 5 Detailed list of induction reagents and corresponding induction time

[0067] category Differences in induction reagent types Induction time Comparative Example 1-1 Only 300 μg / L LPS was added 24h Comparative Example 1-2 Only 300 μg / L LPS was added 72h Comparative Examples 1-3 Only 300 μg / L LPS + 200 μg / L IFNr were added 24h Comparative Examples 1-4 Only 300 μg / L LPS + 200 μg / L IFNr were added 72h

[0068] Comparative Example 2

[0069] This comparative example provides a ready-to-use Raw264.7 cell-directed polarization M1 macrophage combination reagent and its preparation method and application. Its raw materials and methods are basically the same as those in Example 1, except that: the material components in the induction reagent are different, and the rest remain unchanged. The specific differences in the induction reagents are shown in Table 6.

[0070] Table 6 Detailed list of induction reagents and corresponding induction time

[0071]

[0072] Comparative Example 3

[0073] This comparative example provides a ready-to-use Raw264.7 cell-directed polarization M1 macrophage combination reagent and its preparation method and application. The raw materials and methods are basically the same as those in Example 4, except that BSA, trehalose and glycerol are removed from the induction reagent, and the rest remain unchanged.

[0074] Furthermore, in order to understand the induction effects of the above-mentioned embodiments and comparative examples, a test was conducted.

[0075] A blank control group (without induction reagent) was set up, and the FC receptor blocker was added to the M1 macrophage solution obtained in the above embodiments and comparative examples, and incubated at room temperature for 10 minutes; then, the M1 macrophage phenotype marker antibodies CD11b, F4 / 80, CD86, and CD206 were added, and gently blown to mix; then PBS buffer was added to each group, and the cells were gently blown to mix, centrifuged at room temperature at 150g for 3 minutes, and the supernatant was discarded; finally, flow cytometry was used to analyze the proportion of CD11b+F4 / 80+CD86+CD206- cells, which was the proportion of M1 macrophages. The test results are shown in Figure 1-9 .

[0076] Figure 1 It is shown that under a microscope, the uninduced blank cells are round, and the M1 macrophages induced by directional polarization in Examples 1-3 have many large particles in the cell body and obvious cell pseudopodia. Compared with the blank control group, the concentrations of the induction reagents, special culture medium, and digestion medium are within the concentration range described in this patent, and the polarized cultured M1 macrophages have many large particles in the cell body and obvious cell pseudopodia. The RAW264.7 cell directional polarization M1 induction mixture in the figure is the combination reagent in Example 1, the RAW264.7 cell directional polarization M1 induction mixture 2 is the combination reagent in Example 2, and the RAW264.7 cell directional polarization M1 induction mixture 3 is the combination reagent in Example 3.

[0077] Figure 2 The results show that compared with the uninduced blank cells and the isotype control group, the proportion of M1 macrophages, i.e., CD11b+F4 / 80+CD86+CD206- cells, after 24 hours of directional polarization induction in Example 1 was 99%.

[0078] Depend on Figure 3 , 4 It can be seen that: compared with comparative example 1, whether it is long-term induction (72h) or short-term induction (24h), the induction effect of Example 1 is significantly better after changing the type of inducer; among which comparative example 1-1, comparative example 1-2, and comparative example 1-3 in comparative example 1 almost did not induce M1 macrophages, and only comparative example 1-4 induced a small amount, but the induction rate was only 16%.

[0079] Depend on Figure 5 , 6It can be seen that: compared with Comparative Example 2, the induction effect of changing the content of LPS, IFNr, M-CSF, and GM-CSF4 on the basis of the inducer provided in Example 1 is very different. In Comparative Examples 2-1 to 2-10, only a small amount of cells differentiate or no corresponding macrophage differentiation occurs. This indicates that the inducer provided in this application needs to be added with LPS, IFNr, M-CSF, and GM-CSF4 at the same time to achieve the technical effect of short induction time and high induction rate.

[0080] Depend on Figure 7 , 8 It can be seen that compared with the blank control group, the cell inducer without BSA, trehalose and glycerol had a poor effect after freezing and thawing 10 times, and the number of induced Raw264.7 cells differentiated into M1 cells was small. When at least one of BSA, trehalose and glycerol was added, the induced cells were M1 cells with obvious pseudopodia, indicating that adding at least one of BSA, trehalose and glycerol to the mixture can effectively protect the freezing stability of the reagent, and it has the phenotypic characteristics of M1 macrophages CD11b+F4 / 80+CD86+CD206-.

[0081] Depend on Fig. 9 It can be seen that compared with the blank control group, the cell inducer without BSA, trehalose and glycerol had a poor effect after 14 days of heat acceleration at 37°C, and the number of induced Raw264.7 cells differentiated into M1 cells was small. When at least one of BSA, trehalose and glycerol was added, the induced cells were M1 cells with obvious pseudopodia, indicating that adding at least one of BSA, trehalose and glycerol to the mixture can effectively protect the thermal acceleration stability of the reagent.

[0082] Figure 7-9 In the examples, mixture 1 corresponds to Example 3, mixture 2 corresponds to Example 4-1, mixture 3 corresponds to Example 1, mixture 4 corresponds to Example 4-2, and mixture 5 corresponds to Example 4-3.

[0083] In summary, the present invention provides a ready-to-use Raw264.7 cell directional polarization M1 combination reagent and its preparation method and application, which are simple to operate, greatly improve the accuracy of the experiment, and the purity of the M1 target cells is more than 90%, and the induction time is shortened from 72h to 24h, which solves the problems of high difficulty and low purity of Raw264.7 cell polarization M1, and provides favorable support for the subsequent research on the Raw264.7 cell-induced M1 cell model.

[0084] The specific raw materials not described in the present invention are all existing materials and can be directly purchased from the market.

[0085] The above are only preferred embodiments of the present invention and are not intended to limit the protection scope of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A combination reagent for polarizing Raw264.7 cells to M1 macrophages, characterized in that: The combination of agents includes an inducing agent; The induction reagent includes the following components: NaCl 8-10 g / L, KCl 0.5-1.1 g / L, KH2PO4 0.2-0.5 g / L, Na2HPO4 0.5-1.4 g / L, NaHCO3 0.05-0.1 g / L, LPS 0.1-1 g / L, M-CSF 0.1-1 g / L, GM-CSF0.1-1 g / L, IFNr 0.1-0.5 g / L, and at least one of BSA 0.1-3 g / L, trehalose 10-50 g / L, and glycerol 0.1-1%.

2. The combined reagent according to claim 1, characterized in that: The induction reagent includes the following components: NaCl 8.4 g / L, KCl 1.0 g / L, KH2PO4 0.3 g / L, Na2HPO4 0.86 g / L, NaHCO3 0.08 g / L, LPS 0.3 g / L, M-CSF 0.4 g / L, GM-CSF 0.65 g / L, IFNr 0.35 g / L, and at least one of BSA 2 g / L, trehalose 25 g / L, and glycerol 0.8%.

3. The combined reagent according to claim 1 or 2, characterized in that: The combination reagent also includes a special culture medium, which includes the following components: 5-20% fetal bovine serum, 0.1-1 g / L 2-mercaptoethanol, 0.5-2 g / L L-alaninamide, 0.5-2 g / L L-glutamine, and RPMI1640 basic culture medium.

4. The combined reagent according to claim 1 or 2, characterized in that: The combined reagent also includes a digestion medium, which includes the following components: NaCl 8-10 g / L, KCl 0.5-1.1 g / L, KH2PO4 0.2-0.5 g / L, Na2HPO4 0.5-1.4 g / L, 2,6-dimethylaniline 10-20 g / L, and EDTA-2Na 0.1-1 g / L.

5. The method for preparing the combined reagent according to any one of claims 1 to 4, characterized in that: The steps for preparing the induction reagent in the combination reagent are as follows: first, dissolve NaCl, KCl, KH2PO4, Na2HPO4, and NaHCO3 in sterilized ultrapure water, stir to dissolve, then add at least one of BSA, glycerol, and trehalose, stir to dissolve, then adjust the pH to 7.2-7.4, fix the volume, filter through a 0.22 μm filter membrane for sterilization, and store at 4°C to obtain a buffer solution; add LPS, M-CSF, GM-CSF, and IFNr to the above buffer solution, gently blow and mix, and store at -20°C away from light to obtain an induction reagent.

6. The preparation method according to claim 5, characterized in that: The steps for preparing the special culture medium in the combination reagent are as follows: take 2-mercaptoethanol, L-alanine amine, and L-glutamine, add them to RPMI1640 basic culture medium, stir and dissolve in the dark, then add fetal bovine serum, mix well, then adjust the pH to 7.2-7.4, filter through a 0.22 μm filter membrane for sterilization, and store at 4° C. in the dark to obtain the special culture medium.

7. The preparation method according to claim 5, characterized in that: The steps for preparing the digestion medium in the combined reagent are as follows: dissolve NaCl, KCl, KH2PO4, Na2HPO4, and 2,6-dimethylaniline in sterilized ultrapure water, stir to dissolve, then add EDTA-2Na, stir to dissolve, adjust the pH to 7.2-7.4, make up to volume, filter through a 0.22 μm filter membrane for sterilization, and store at 4° C. to obtain the digestion medium.

8. The method for obtaining M1 macrophages by using the combination reagent of any one of claims 1 to 4 through directional polarization of Raw264.7, characterized in that: The following steps are involved: S1, pipette Raw264.7 cells, centrifuge, discard the supernatant, resuspend the cell pellet with a special culture medium, count the cells, adjust the cell density, and inoculate in a cell culture dish; S2, add induction reagent, transfer to CO2 incubator at 37℃ and culture for 22-26h, remove supernatant, add special culture medium, shake to wash, and discard supernatant; S3, add digestion medium, shake to soak, and incubate in a CO2 incubator at 37°C for 2 to 5 minutes, and digestion is complete; S4. Collect the digested cells by blowing the cell dish, centrifuge, discard the supernatant, and resuspend the cell pellet with PBS buffer to obtain M1 macrophages.

9. The method according to claim 8, characterized in that The cell density in step S1 is 1 to 5×10 5 / mL, and the centrifugation conditions were all 140-160g for 2-4min; the amount of induction reagent added in step S2 was 1 μL of induction reagent added to 1mL of cell suspension; the centrifugation conditions in S3 were all 140-160g for 2-4min.

10. A ready-to-use Raw264.7 cell polarization M1 macrophage kit, characterized in that: The kit comprises the combined reagent according to any one of claims 1 to 4.